VF
CBPO

Virtu Financial’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Virtu Financial’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,871
Closed -$233K – 2824
2018
Q1 		$233K Buy
+2,871
New +$232K 0.01% 1246
2017
Q4 		– Sell
-2,870
Closed -$265K – 3431
2017
Q3 		$265K Buy
+2,870
New +$276K 0.01% 1518

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's CBPO Position: Q2 2018 in Review

Virtu Financial sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 2,871 shares — an estimated $233K sold.

Virtu Financial first reported a position in CBPO in Q3 2017 and held it in 2 quarters. The position peaked at $265K in Q3 2017. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

  • Virtu Financial reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
  • Virtu Financial sold 2,871 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $233K.
  • Virtu Financial first reported a position in China Biologic Products Holdings, Inc. in Q3 2017 and held it in 2 quarters.
  • Virtu Financial's China Biologic Products Holdings, Inc. position peaked at $265K in Q3 2017.
  • 91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.